Table 2.
Characteristics and outcomes of patients with basal cell carcinoma recurrences.
| Age/Gender | Lesion location | Risk factors | Initial surgery | BCC subtype | Tumour clearance achieved? | Narrowest margin (mm) and location | Further surgery? | Interval between last surgery and recurrence (months) | Further surgery? | Tumour clearance achieved? | Further recurrence? | Final follow up after second surgery (months?) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77 M | L LL | None | MMS | Infiltrative | Yes | N/A | N/A | 12 | WLE | Yes | No | 24 |
| 75 M | R LL | Previous mesothelioma – RTx. Steroids for ITP. | Fast paraffin | Nodular | No | 0.3 (deep) | No | 60 | MMS | Yes | No | 12 |
| 70 F | L LC | BCCs elsewhere, positive FHx | WLE | Mixed – infiltrative + superficial | No | 0.3 (peripheral) | No | 36 | MMS | Yes | No | 18 |
BCC Basal cell carcinoma, M Male, F Female, L Left, R Right, LL Lower lid, LC Lateral canthus, RTx Radiotherapy, ITP Immune thrombocytopenic purpura, FHx Family history, MMS Mohs micrographic surgery, WLE Wide local excision, N/A Not applicable.